{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:23:14Z","timestamp":1794561794186,"version":"4.9.1"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,2,27]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The C reactive protein polymyalgia rheumatica activity score (CRP-PMR-AS) is a composite index that includes CRP levels and was developed specifically for PMR. As treatments such as interleukin-6 antagonists can normalise CRP levels, the erythrocyte sedimentation rate (ESR) of PMR-AS, the clinical (clin)-PMR-AS and the imputed-CRP (imp-CRP)-PMR-AS have been developed to avoid such bias. Our primary objective was to measure the correlation of these activity scores. Our secondary objective was to evaluate the concordance between different cutoffs of the PMR-ASs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Data from the Safety and Efficacy of tocilizumab versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence (SEMAPHORE) trial, a superiority randomised double-blind placebo-controlled trial, were subjected to post hoc analysis to compare the efficacy of tocilizumab versus placebo in patients with active PMR. The CRP-PMR-AS, ESR-PMR-AS, clin-PMR-AS and imp-CRP-PMR-AS were measured at every visit. The concordance and correlation between these scores were evaluated using kappa correlation coefficients, Bland-Altman correlations, intraclass correlation coefficients (ICCs) and scatter plots.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 101 patients were included in the SEMAPHORE trial, and 100 were analysed in this study. The correlation between the PMR-ASs was excellent, as the ICC and kappa were &gt;0.85 from week 4 until week 24 (CRP-PMR-AS \u226410 or &gt;10). Bland-Altman plots revealed that the differences between the CRP-PMR-AS and the other three<\/jats:p>\n                    <jats:p>scores were low. The cut-off values for the clin-PMR-AS were similar to those for the CRP-PMR-AS 86% of the time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The correlation between all the PMR-ASs was excellent, reflecting the low weight of CRP. In clinical trials using drugs that have an impact on CRP, the derived activity scores can be used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NTC02908217.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003741","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:55:29Z","timestamp":1710500129000},"page":"e003741","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Concordance and agreement between different activity scores in polymyalgia rheumatica"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8768-3821","authenticated-orcid":false,"given":"Justine","family":"D'Agostino","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aghiles","family":"Souki","sequence":"additional","affiliation":[{"name":"Public Agency for Clinical Research and Innovation (DRCI), Brest University Hospital, Centre Hospitalier Universitaire de Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lohse","sequence":"additional","affiliation":[{"name":"Hopital Nord Franche-Comte\u2014Site de Belfort, Belfort, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5281-5445","authenticated-orcid":false,"given":"Guillermo","family":"Carvajal Alegria","sequence":"additional","affiliation":[{"name":"Rheumatology and EA6295 NMNS, Centre Hospitalier R\u00e9gional Universitaire de Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle","family":"Dernis","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Le Mans, Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-8739","authenticated-orcid":false,"given":"Christophe","family":"Richez","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin, Bordeaux, France"},{"name":"UMR CNRS 5164, Universit\u00e9 de Bordeaux Coll\u00e8ge Sciences de la Sant\u00e9, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8045-0180","authenticated-orcid":false,"given":"Marie-Elise","family":"Truchetet","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4687-5780","authenticated-orcid":false,"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[{"name":"Rheumatology and EA4266 Franche-Comt\u00e9 University, Centre Hospitalier Universitaire de Besancon, Besancon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6228-1464","authenticated-orcid":false,"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[{"name":"INSERM Clinical Investigation Center 1431, Centre Hospitalier Universitaire de Besancon, Besancon, France"},{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Besancon, Besancon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleth","family":"Perdriger","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Rennes, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-946X","authenticated-orcid":false,"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-4032","authenticated-orcid":false,"given":"Renaud","family":"Felten","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8845-4274","authenticated-orcid":false,"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Assistance Publique-Hopitaux de Paris, Paris, France"},{"name":"INSERM UMR-S 1136, Pierre Louis Epidemiology and Public Health Research Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chiche","sequence":"additional","affiliation":[{"name":"Internal Medicine, Marseille Public University Hospital System, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Hilliquin","sequence":"additional","affiliation":[{"name":"Department of Rhumatology, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Le Henaff","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Pays de Morlaix Hospital Centre, Morlaix, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dervieux","sequence":"additional","affiliation":[{"name":"Department of Rhuamtology, GHR Mulhouse Sud Alsace, Mulhouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Direz","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Le Mans, Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Chary-Valckenaere","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Nancy, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9159-702X","authenticated-orcid":false,"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, France"},{"name":"INSERM 1227, Universit\u00e9 de Bretagne Occidentale, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Guellec","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, France"},{"name":"INSERM Clinical Investigations Centre 1412, Centre Hospitalier Universitaire de Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Marhadour","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Nowak","sequence":"additional","affiliation":[{"name":"Public Agency for Clinical Research and Innovation (DRCI), Brest University Hospital, Centre Hospitalier Universitaire de Brest, Brest, France"},{"name":"Centre Hospitalier Universitaire de Brest, Brest, INSERM Clinical Investigations Centre (CIC) 1412, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-7067","authenticated-orcid":false,"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, France"},{"name":"INSERM 1227, Universit\u00e9 de Bretagne Occidentale, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire de Brest, Brest, France"},{"name":"INSERM 1227, Universit\u00e9 de Bretagne Occidentale, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"2025090313413524000_10.1.e003741.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5444"},{"key":"2025090313413524000_10.1.e003741.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200329"},{"key":"2025090313413524000_10.1.e003741.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223429"},{"key":"2025090313413524000_10.1.e003741.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.013"},{"key":"2025090313413524000_10.1.e003741.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.002618"},{"key":"2025090313413524000_10.1.e003741.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011379"},{"key":"2025090313413524000_10.1.e003741.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208742"},{"key":"2025090313413524000_10.1.e003741.8","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06263-3","article-title":"Polymyalgia Rheumatica treatment with methotrexate in optimal dose in an early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial","volume":"23","author":"Marsman","year":"2022","journal-title":"Trials"},{"key":"2025090313413524000_10.1.e003741.9","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2665-9913(23)00032-2","article-title":"1-year results of treatment with Rituximab in Polymyalgia Rheumatica: an extension study of a randomised double-blind placebo-controlled trial","volume":"5","author":"Bolhuis","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2025090313413524000_10.1.e003741.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31825-1"},{"key":"2025090313413524000_10.1.e003741.11","first-page":"65","article-title":"Relapse in a population based cohort of patients with Polymyalgia Rheumatica","volume":"32","author":"Kremers","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090313413524000_10.1.e003741.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.20901"},{"key":"2025090313413524000_10.1.e003741.13","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2017.922"},{"key":"2025090313413524000_10.1.e003741.14","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.39740","article-title":"Brief report: A prospective open-label phase IIa trial of Tocilizumab in the treatment of Polymyalgia Rheumatica: TCZ IN THE TREATMENT OF PMR","volume":"68","author":"Lally","year":"2016","journal-title":"Arthritis & Rheumatology"},{"key":"2025090313413524000_10.1.e003741.15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.2022.15459","article-title":"Effect of Tocilizumab on disease activity in patients with active Polymyalgia Rheumatica receiving glucocorticoid therapy: A randomized clinical trial","volume":"328","author":"Devauchelle-Pensec","year":"2022","journal-title":"JAMA"},{"key":"2025090313413524000_10.1.e003741.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221126"},{"key":"2025090313413524000_10.1.e003741.17","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2665-9913(21)00245-9","article-title":"Efficacy of Rituximab in patients with Polymyalgia Rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial","volume":"3","author":"Marsman","year":"2021","journal-title":"The Lancet Rheumatology"},{"key":"2025090313413524000_10.1.e003741.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210455"},{"key":"2025090313413524000_10.1.e003741.19","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223562"},{"key":"2025090313413524000_10.1.e003741.20","unstructured":"University Hospital, Brest . Baricitinib healing effect in earLy pOlymyalgia Rheumatica (BACHELOR study). 2022. Available: https:\/\/clinicaltrials.gov\/study\/NCT04027101"},{"key":"2025090313413524000_10.1.e003741.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16665","article-title":"Reduced C-reactive protein level at hospital admission in patients treated with Tocilizumab \u2013 an attention may be required","volume":"9","author":"Berman","year":"2023","journal-title":"Heliyon"},{"key":"2025090313413524000_10.1.e003741.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.02.004"},{"key":"2025090313413524000_10.1.e003741.23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/art.40876","article-title":"Glucocorticoid dosages and acute-phase Reactant levels at giant cell arteritis flare in a randomized trial of Tocilizumab","volume":"71","author":"Stone","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2025090313413524000_10.1.e003741.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216607"},{"key":"2025090313413524000_10.1.e003741.25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/rheumatology\/kex477","article-title":"Assessing Polymyalgia Rheumatica activity when C-reactive protein is unavailable or Uninterpretable","volume":"57","author":"Devauchelle-Pensec","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313413524000_10.1.e003741.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.22771"},{"key":"2025090313413524000_10.1.e003741.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.23338"},{"key":"2025090313413524000_10.1.e003741.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088526"},{"key":"2025090313413524000_10.1.e003741.29","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110866"},{"key":"2025090313413524000_10.1.e003741.30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2307\/2987937","article-title":"Measurement in medicine: the analysis of method comparison studies","volume":"32","author":"Altman","year":"1983","journal-title":"The Statistician"},{"key":"2025090313413524000_10.1.e003741.31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the Kappa Statistic","volume":"276\u201382","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"key":"2025090313413524000_10.1.e003741.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613849"},{"key":"2025090313413524000_10.1.e003741.33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213920"},{"key":"2025090313413524000_10.1.e003741.34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/acr.22110","article-title":"Phase III study of the efficacy and safety of subcutaneous versus intravenous Tocilizumab monotherapy in patients with rheumatoid arthritis","volume":"66","author":"Ogata","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313413524000_10.1.e003741.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2025090313413524000_10.1.e003741.36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew202"},{"key":"2025090313413524000_10.1.e003741.37","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1499-2","article-title":"Ultrasonography and magnetic resonance imaging changes in patients with Polymyalgia Rheumatica treated by Tocilizumab","volume":"20","author":"Huwart","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025090313413524000_10.1.e003741.38","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13030514","article-title":"Diagnostic value of composite and simplified FDG-PET\/CT scores in Polymyalgia Rheumatica and the influence of recent glucocorticoid treatment\u2014A retrospective diagnostic cohort study","volume":"13","author":"Brinth","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2025090313413524000_10.1.e003741.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152010","article-title":"The glucocorticoid toxicity index: measuring change in glucocorticoid toxicity over time","volume":"55","author":"Stone","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313413524000_10.1.e003741.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110977"},{"key":"2025090313413524000_10.1.e003741.41","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1093\/rheumatology\/keab158","article-title":"Upadacitinib improves patient-reported outcomes vs placebo or Adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE","volume":"60","author":"Strand","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313413524000_10.1.e003741.42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.semarthrit.2018.03.006","article-title":"The use of routinely collected patient-reported outcome measures in rheumatoid arthritis","volume":"48","author":"Hiligsmann","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313413524000_10.1.e003741.43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/rheumatology\/keac317","article-title":"Development and Psychometric evaluation of the PMR-impact scale: a new patient reported outcome measure for Polymyalgia Rheumatica","volume":"62","author":"Twohig","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313413524000_10.1.e003741.44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.8.883"},{"key":"2025090313413524000_10.1.e003741.45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41584-020-0458-5","article-title":"Monitoring and long-term management of giant cell arteritis and Polymyalgia Rheumatica","volume":"16","author":"Camellino","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025090313413524000_10.1.e003741.46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105529","article-title":"The future of Polymyalgia Rheumatica research: what can we learn from rheumatoid arthritis","volume":"90","author":"Moreel","year":"2023","journal-title":"Joint Bone Spine"},{"key":"2025090313413524000_10.1.e003741.47","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211292"},{"key":"2025090313413524000_10.1.e003741.48","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190575"},{"key":"2025090313413524000_10.1.e003741.49","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200248"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:41:45Z","timestamp":1756932105000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/rmdopen-2023-003741"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003741","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}